Repare Therapeutics Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities
Repare Therapeutics Inc. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $2.38 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2025-03-03
- Repare Therapeutics Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2020-12-31 was $96.00K.
- Repare Therapeutics Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2024 was $2.38M, a 22.95% decline from fiscal 2023.
- Repare Therapeutics Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $3.09M, a 57.12% increase from fiscal 2022.
- Repare Therapeutics Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $1.97M, a 719.17% increase from fiscal 2021.
- Repare Therapeutics Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2021 was $240.00K, a 11.11% increase from fiscal 2020.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|
| 2024-12-31 | $2.38M 10-K · filed 2025-03-03 | ||
| 2023-12-31 | $3.09M 10-K · filed 2025-03-03 | ||
| 2022-12-31 | $1.97M 10-K · filed 2024-02-28 | ||
| 2021-12-31 | $240.00K 10-K · filed 2023-02-28 | ||
| 2020-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $216.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $120.00K 10-Q · filed 2020-11-12 |